GRACE DUGGAN: Open Payments
NPI 1346012895 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $116 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $179 |
| Impulse Dynamics (USA) Inc. | 2 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $166 |
| Novartis Pharmaceuticals Corporation | 5 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Edwards Lifesciences Corporation | 1 | $50 |
| United Therapeutics Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| CVRx, Inc. | 1 | $21 |
| AtriCure, Inc. | 1 | $20 |
Products named: Optimizer, LIVTENCITY, Repatha, LEQVIO, Kerendia, PASCAL, TYVASO, Barostim Neo System.
Industry payments across TX — which companies pay providers there.
